SXI Life Sciences
6.306,45
PKT
-366,93
PKT
-5,50
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
06.05.24 | Novartis Buy | UBS AG | |
26.04.24 | Novartis Buy | Jefferies & Company Inc. | |
25.04.24 | Roche Neutral | UBS AG | |
25.04.24 | Roche Equal Weight | Barclays Capital | |
24.04.24 | Roche Kaufen | DZ BANK | |
24.04.24 | Novartis Buy | UBS AG | |
24.04.24 | Roche Equal Weight | Barclays Capital | |
24.04.24 | Novartis Buy | Deutsche Bank AG | |
24.04.24 | Roche Neutral | UBS AG | |
24.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
24.04.24 | Roche Hold | Jefferies & Company Inc. | |
24.04.24 | Roche Outperform | Bernstein Research | |
24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
23.04.24 | Novartis Underweight | Barclays Capital | |
23.04.24 | Novartis Buy | UBS AG | |
23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
18.04.24 | Roche Neutral | UBS AG | |
18.04.24 | Novartis Buy | UBS AG | |
18.04.24 | Novartis Buy | Deutsche Bank AG | |
15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
11.04.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
10.04.24 | Novartis Buy | UBS AG | |
09.04.24 | Roche Neutral | UBS AG | |
08.04.24 | Roche Equal Weight | Barclays Capital | |
05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
04.04.24 | Novartis Buy | UBS AG | |
03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
02.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
28.03.24 | Novartis Underweight | Barclays Capital | |
25.03.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.03.24 | Roche Sell | Deutsche Bank AG | |
22.03.24 | Novartis Buy | Deutsche Bank AG | |
21.03.24 | Roche Sell | Deutsche Bank AG | |
20.03.24 | Roche Neutral | UBS AG | |
12.03.24 | Roche Sell | Deutsche Bank AG | |
12.03.24 | Roche Equal Weight | Barclays Capital | |
26.02.24 | Roche Hold | Jefferies & Company Inc. |